AI in Community Oncology: COA's Digital Transformation Strategy

What happened

Debra Patt, a prominent voice in community oncology, has outlined a strategic vision for embedding artificial intelligence and digital transformation tools into independent cancer care practices, working through the Community Oncology Alliance (COA). Her argument centres on the idea that community oncology — care delivered close to where patients live rather than in large academic hospital systems — stands to benefit disproportionately from well-implemented AI, precisely because these practices operate under tighter resource constraints than their institutional counterparts.

Patt's framework, as reported by Oncodaily, addresses several operational and clinical domains: prior authorisation workflows, clinical documentation, treatment decision support and patient communication. The thrust is that AI should reduce the administrative burden that has long squeezed independent oncology practices, freeing clinicians to spend more time on direct patient care. COA is positioned as the organising body through which these capabilities can be standardised and scaled across the community setting.

The initiative reflects a broader shift in oncology care delivery, where the viability of independent practices is under sustained financial and regulatory pressure. Digital tools, in this framing, are not merely efficiency plays — they are presented as a structural defence for a care model that keeps treatment accessible and local.

Why it matters

For customer experience and service-design practitioners, this story is a reminder that the "customer" in healthcare is a patient navigating one of the most emotionally and cognitively demanding journeys imaginable. When AI absorbs prior authorisation delays or reduces the time a clinician spends on paperwork, the downstream effect is a measurably different human experience: shorter waits, more attentive consultations, faster answers. These are not incidental improvements — they map directly onto the behavioral economics of trust, perceived competence and emotional safety that determine whether patients engage with their care plans or disengage.

The community oncology context adds a service-design dimension that is easy to overlook. Independent practices are, in effect, small service businesses competing against vertically integrated hospital systems. Their competitive advantage is relational continuity — patients know their care team. AI that protects clinician time protects that relationship. Any operator designing patient-facing services in high-stakes, high-emotion categories should pay close attention to this model.

The Renascence take

Most coverage of AI in healthcare fixates on diagnostic accuracy or drug discovery. The more consequential near-term story is far more mundane — and far more human: who answers the phone, how quickly a treatment gets approved, whether a nurse has three minutes or thirty seconds to explain a side effect. Patt's COA-led agenda is really a customer experience programme dressed in clinical language.

The dominant mistake in healthcare digital transformation is optimising for throughput rather than for the patient's felt experience of being cared for. Reducing prior authorisation friction is not an administrative win — it is a behavioral intervention that lowers patient anxiety and increases treatment adherence. Community oncology practices that frame AI adoption through the lens of relationship preservation, rather than cost reduction alone, will build the kind of loyalty that no hospital system's marketing budget can replicate. The question every operator should ask is not "what can AI automate?" but "what does automation give back to the human in the room?"